Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a research report issued on Thursday, Benzinga reports. They currently have a $200.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s price objective suggests a potential upside of 33.49% from […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) shares hit a new 52-week low on Thursday . The company traded as low as $143.52 and last traded at $146.04, with a volume of 1235397 shares trading hands. The stock had previously closed at $164.15. Wall Street Analyst Weigh In ALNY has been the topic of […]
Cantor Fitzgerald Reaffirms Neutral Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Stock analysts at Leerink Partnrs increased their FY2023 EPS estimates for Alnylam Pharmaceuticals in a research report issued on Monday, January 8th. Leerink Partnrs analyst M. Foroohar now anticipates that the biopharmaceutical company will post earnings of ($2.49) per share for the year, up from their prior […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty research firms that are currently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year price […]